Literature DB >> 4811964

Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.

A Nicholson, V Brade, G D Lee, H S Shin, M M Mayer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4811964

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  17 in total

1.  Binding of the complement intermediate C56 to zymosan in acute phase human sera.

Authors:  P J Baker; L G Rubin; T F Lint; B C McLeod; H Gewurz
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Classical and alternative complement pathway activation by pneumococci.

Authors:  C G Stephens; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

Review 3.  The internal thioester and the covalent binding properties of the complement proteins C3 and C4.

Authors:  S K Law; A W Dodds
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

4.  Effects of activated complement components on enzyme secretion by macrophages.

Authors:  H U Schorlemmer; A C Allison
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

5.  Interaction between the third complement protein and cell surface macromolecules.

Authors:  S K Law; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

6.  Inhibition of neutrophil function by fluid phase C3b of complement.

Authors:  J D Ogle; C K Ogle; J W Alexander
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption.

Authors:  R Snyderman; M C Pike
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

8.  Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.

Authors:  M Takahashi; S Takahashi; V Brade; V Nussenzweig
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

9.  Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.

Authors:  A Nicholson-Weller; J P March; S I Rosenfeld; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.

Authors:  P J Lachmann; L Halbwachs
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.